irinotecan has been researched along with baicalein in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Igarashi, A; Satoh, T; Takahashi-Suzuki, N; Tanno, M; Watanabe, K; Yamada, K | 1 |
| Chen, LC; Cheng, WJ; Hsieh, CM; Hung, MT; Lin, HL; Lin, SY; Sheu, MT | 1 |
| Pei, J; Wang, Y; Zhou, W; Zou, Y | 1 |
3 other study(ies) available for irinotecan and baicalein
| Article | Year |
|---|---|
Inhibitory Effects of Baicalein Derived from Japanese Traditional Herbal Medicine on SN-38 Glucuronidation.
Topics: Enzyme Inhibitors; Flavanones; Glucuronidase; Glucuronides; Glycyrrhizic Acid; Herbal Medicine; Humans; Irinotecan; Japan; Kinetics; Microsomes, Liver; Time Factors | 2018 |
CPT11 with P-glycoprotein/CYP 3A4 dual-function inhibitor by self-nanoemulsifying nanoemulsion combined with gastroretentive technology to enhance the oral bioavailability and therapeutic efficacy against pancreatic adenocarcinomas.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Survival; Chemistry, Pharmaceutical; Cytochrome P-450 Enzyme Inhibitors; Drug Delivery Systems; Drug Liberation; Emulsions; Flavanones; Glycyrrhetinic Acid; Glycyrrhizic Acid; Half-Life; Irinotecan; Mice; Nanoparticles; Pancreatic Neoplasms; Rabbits; Random Allocation; Silymarin; Xenograft Model Antitumor Assays | 2021 |
Baicalein, a component of banxia xiexin decoction, alleviates CPT-11-induced gastrointestinal dysfunction by inhibiting ALOX15-mediated ferroptosis.
Topics: Animals; Arachidonate 15-Lipoxygenase; Diarrhea; Ferroptosis; Irinotecan; Rats | 2023 |